Innate Killer Summit 2022

2021 has been a game-changing year for the NK cell community. Positive clinical results have forced the field to wake up to the potential of these pioneering approaches.

Supporting the field since its’ infancy, the Innate Killer Summit returns for its 7^th year as the leading, industry-defining forum dedicated to advancing the field to achieve clinical success.

Spanning the current drug development landscape, from improving gene editing transduction in discovery to cryopreservation and CMC in scaled manufacturing, this is the definitive meeting to focus on the clinical and scaled phase development of innate cell therapies.